Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Company's Revenue for Reportable Segment by Country Based on Locations of Customer

The following represents the Company’s revenue for its reportable segment by country, based on the locations of the customer (in thousands).

	For the Year Ended December 31, 2021
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	26,202	$	21,264	$	66,991	$	114,457
China		33		2,633		—		2,666
South Korea		—		1,112		—		1,112
India		—		906		—		906
Other Foreign Countries		631		409		—		1,040
Total Revenue	$	26,866	$	26,324	$	66,991	$	120,181

	For the Year Ended December 31, 2020
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	—	$	12,079	$	70,283	$	82,362
China		38,760		1,036		—		39,796
United Kingdom		—		—		19,289		19,289
South Korea		—		2,354		—		2,354
Other Foreign Countries		91		499		—		590
Total Revenue	$	38,851	$	15,968	$	89,572	$	144,391

	For the Year Ended December 31, 2019
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	—	$	17,367	$	50,427	$	67,794
Spain		20,000		—		—		20,000
Austria		—		4,422		—		4,422
India		—		3,066		—		3,066
China		562		1,543		—		2,105
United Kingdom		—		1,023		—		1,023
Other Foreign Countries		—		2,819		—		2,819
Total Revenue	$	20,562	$	30,240	$	50,427	$	101,229

Summary of Receivables and Contract Liabilities From Contracts with Customers

The following table provides information about receivables and contract liabilities from contracts with customers. The Company has not recorded any contract assets from contracts with customers (in thousands).

	December 31,
	2021			2020
Accounts receivable, gross	$	58,811		$	45,792
Chargebacks and other deductions		(22,868	)		(12,552	)
Provision for credit losses		(9,306	)		(9,637	)
Accounts receivable, net	$	26,637		$	23,603
Deferred revenue		3,291			1,147
Total contract liabilities	$	3,291		$	1,147

Summary of Accounts Receivable by Reportable Segments

The following tables illustrate accounts receivable by reportable segments (in thousands).

	December 31, 2021
	Oncology Innovation Platform			Global Supply Chain Platform			Commercial Platform			Consolidated Total
Accounts receivable, gross	$	10,069		$	4,444		$	44,298		$	58,811
Chargebacks and other deductions		—			—			(22,868	)		(22,868	)
Provision for credit losses		(8,919	)		(290	)		(97	)		(9,306	)
Accounts receivable, net	$	1,150		$	4,154		$	21,333		$	26,637

	December 31, 2020
	Oncology Innovation Platform			Global Supply Chain Platform			Commercial Platform			Consolidated Total
Accounts receivable, gross	$	10,783		$	4,074		$	30,935		$	45,792
Chargebacks and other deductions		—			(1	)		(12,551	)		(12,552	)
Provision for credit losses		(8,919	)		(164	)		(554	)		(9,637	)
Accounts receivable, net	$	1,864		$	3,909		$	17,830		$	23,603